Learn about important clinical advances in HIV biomedical prevention that have taken place over the past year, including updates in pre-exposure prophylaxis eligibility considerations and regimen selection, the emergence of a new long-acting injectable option, the latest insights on population-specific strategies, expert perspectives on improving equity in access, and broadening prevention strategies for other STIs.
Darrell H. S. Tan, MD, FRCPC, PhD